Create new account

Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
Cart

Your cart is empty, just add some products

This is a fantastic opportunity to fill the cart with something really special!

Estimated shipping

0,00 €

Total: 0,00 €

image/svg+xml +372 5656 0050, +370 (620) 70159
image/svg+xml Log in / Register
Log in or register
Log in Create account
Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
1-placeholder

SKU A0121/6

The fully automated Idylla™ GeneFusion Assay detects ALK, ROS1, RET, NTRK1/2/3 rearrangements & MET Exon 14 skipping in a single cartridge.

DETECTION OF KNOWN AND NOVEL FUSIONS

The new Idylla™ GeneFusion Assay is a unique combination of 2 detection technologies:

  1. Direct Detection: Highly sensitive detection of known fusion isoforms by RT-qPCR of sample RNA.
  2. Expression Imbalance Analysis: Detection of fusion events without knowledge of the fusion partners by analyzing expression ratios between the 5’ and 3’ ends of the gene.

SPECIMEN REQUIREMENTS

One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the Idylla™ system only a minimal amount of sample is needed:

  • If ≥ 20 mm² tissue area -> 1 x 5 μm FFPE tissue section
  • If < 20 mm² tissue area -> 3 x 5 μm FFPE tissue sections
  • ≥ 10% neoplastic cell content

Idylla™ GeneFusion Assay is for Research Use Only, not for use in diagnostic procedures

Patents US 7,700,339, 8,168,383, 8,481,279, 8,486,645, 8,232,060, 8,288,102, 8,377,642, 9,988,688, 9,523,130, 9,096,855, 10,526,661, 9,364,477, 9,539,254, 10,551,383 and pending US applications and all their respective foreign equivalents under license from Cell Signaling Technology, Inc. This product contains SuperScript™ III Reverse Transcriptase and is provided subject to a license under patents or patent applications owned by or licensed to Life Technologies Corporation, which license is limited to the human diagnostic field and research field and specifically excludes applications in forensics (including human identity testing). The SuperScript™ III trademark is owned by Life Technologies Corporation.

Specifications

Specifications

Documents

GeneFusion_Leaflet.pdf

Idylla GeneFusion Leaflet

EN | 1,384 MB

Download

Techn-Sheet.pdf

Idylla GeneFusion RUO Techical Sheet

EN | 119,734 KB

Download

Specimen_Requirements.pdf

Specimen Requirements

EN | 115,054 KB

Download

Idylla-Brochure.pdf

Idylla Oncology Brochure

EN | 3,128 MB

Download

Recently viewed

Contact

Nova Natura UAB

Chemijos G. 11, LT-51347,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Kanali tee 6, 10112,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

Categories

Let’s stay in touch

Certification9001